To include your compound in the COVID-19 Resource Center, submit it here.

Boehringer Ingelheim, Eli Lilly sales and marketing update

Boehringer and partner Eli Lilly launched once-daily Tradjenta linagliptin

Read the full 96 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE